A novel approach to target enhancer-addicted cancers
A chromatin degrader stops transcription factors from driving cancer, which may serve as a potential treatment approach for over 90% of prostate cancers
03-Jan-2022 -
While researchers have identified several genes that drive prostate cancer, a new study published in Nature reveals the puppet master controlling the strings.
The strings: Cancer-causing genes, or oncogenes, such as androgen receptor, FOXA1, ERG and MYC.
The puppet master: A chromatin remodeling ...
cancer
chromatin
gene expression
+3